Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NetEase Inc (NTES) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

NetEase IncTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

NetEase Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? NetEase Inc trades at $123 (market cap $76.90B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: NetEase Inc is far larger — about 33.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and NetEase Inc pays a 2.43% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.

NTESSLS
Market Cap
$76.90B$2.28B
Volume
494,8393,128,960
Sector
TechnologyHealth
52-Week High
$152.85$15.46
52-Week Low
$109.26$1.39
Typical Hold Time
74 Days—
Enterprise Value
$52.62B$2.15B
Dividend Yield
2.43%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NetEase Inc

NTES trades at $119.60, up 0.45% today, with a neutral technical signal. The company reported Q2 2026 revenue of $4.4 billion, up 8% year-over-year, though EPS missed estimates due to investment losses. Gross margins improved significantly, and the balance sheet remains strong with $137.58 billion in cash. Revenue growth has been steady, with 2025 revenue reaching $112.63 billion and net income at $33.76 billion.

The outlook is positive given strong profitability, a robust balance sheet, and analyst consensus favoring a buy rating with a $168 price target. Risks include earnings volatility, competitive pressures in gaming, and macroeconomic headwinds affecting Chinese tech stocks. The stock presents a value opportunity with a P/E of 16.06, below industry averages.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NTES
54% Buy46% Sell
Avg holding period · 74 Days
SLS

No sentiment data available yet.

About NetEase Inc

NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).

Read more on NTES →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →